Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Mark Drazen, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Drazen and Gregory Curfman.
Connection Strength

15.346
  1. Where is the surgeon general? N Engl J Med. 2014 Nov 13; 371(20):1928-9.
    View in: PubMed
    Score: 0.594
  2. Vivek Murthy for Surgeon General. N Engl J Med. 2014 May 08; 370(19):1843-4.
    View in: PubMed
    Score: 0.570
  3. ACA standoff. N Engl J Med. 2013 Nov 28; 369(22):e30.
    View in: PubMed
    Score: 0.553
  4. Affirmative action in the balance. N Engl J Med. 2013 Jan 03; 368(1):73-4.
    View in: PubMed
    Score: 0.525
  5. Prescriptions, privacy, and the First Amendment. N Engl J Med. 2011 May 26; 364(21):2053-5.
    View in: PubMed
    Score: 0.467
  6. Products at risk. N Engl J Med. 2010 Oct 28; 363(18):1763.
    View in: PubMed
    Score: 0.448
  7. Sibutramine--another flawed diet pill. N Engl J Med. 2010 Sep 02; 363(10):972-4.
    View in: PubMed
    Score: 0.446
  8. Health care reform 2009 at healthcarereform.nejm.org. N Engl J Med. 2009 Aug 13; 361(7):709-10.
    View in: PubMed
    Score: 0.414
  9. Tobacco, public health, and the FDA. N Engl J Med. 2009 Jul 23; 361(4):402-3.
    View in: PubMed
    Score: 0.411
  10. The Medical Device Safety Act of 2009. N Engl J Med. 2009 Apr 09; 360(15):1550-1.
    View in: PubMed
    Score: 0.403
  11. Physicians and the First Amendment. N Engl J Med. 2008 Dec 04; 359(23):2484-5.
    View in: PubMed
    Score: 0.394
  12. The FDA and tobacco regulation. N Engl J Med. 2008 Sep 04; 359(10):1056-7.
    View in: PubMed
    Score: 0.389
  13. Ezetimibe and cancer--an uncertain association. N Engl J Med. 2008 Sep 25; 359(13):1398-9.
    View in: PubMed
    Score: 0.388
  14. Cardiac transplantation in infants. N Engl J Med. 2008 Aug 14; 359(7):749-50.
    View in: PubMed
    Score: 0.387
  15. Guns and health. N Engl J Med. 2008 Jul 31; 359(5):517-8.
    View in: PubMed
    Score: 0.384
  16. Why doctors should worry about preemption. N Engl J Med. 2008 Jul 03; 359(1):1-3.
    View in: PubMed
    Score: 0.384
  17. Peer review in the balance. N Engl J Med. 2008 May 22; 358(21):2276-7.
    View in: PubMed
    Score: 0.381
  18. Cholesterol lowering and ezetimibe. N Engl J Med. 2008 Apr 03; 358(14):1507-8.
    View in: PubMed
    Score: 0.377
  19. Handgun violence, public health, and the law. N Engl J Med. 2008 Apr 03; 358(14):1503-4.
    View in: PubMed
    Score: 0.376
  20. Physicians and execution. N Engl J Med. 2008 Jan 24; 358(4):403-4.
    View in: PubMed
    Score: 0.371
  21. A pivotal medical-device case. N Engl J Med. 2008 Jan 03; 358(1):76-7.
    View in: PubMed
    Score: 0.371
  22. Open clinical trials. N Engl J Med. 2007 Oct 25; 357(17):1756-7.
    View in: PubMed
    Score: 0.365
  23. No child left uncovered. N Engl J Med. 2007 Sep 06; 357(10):1036-7.
    View in: PubMed
    Score: 0.363
  24. Safer drugs for the American people. N Engl J Med. 2007 Aug 09; 357(6):602-3.
    View in: PubMed
    Score: 0.359
  25. Rosiglitazone--continued uncertainty about safety. N Engl J Med. 2007 Jul 05; 357(1):63-4.
    View in: PubMed
    Score: 0.356
  26. Drug-eluting coronary stents--promise and uncertainty. N Engl J Med. 2007 Mar 08; 356(10):1059-60.
    View in: PubMed
    Score: 0.349
  27. Retraction: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13. N Engl J Med. 2006 Nov 02; 355(18):1927.
    View in: PubMed
    Score: 0.342
  28. Blueprint for a stronger Food and Drug Administration. N Engl J Med. 2006 Oct 26; 355(17):1821.
    View in: PubMed
    Score: 0.340
  29. Expression of concern reaffirmed. N Engl J Med. 2006 Mar 16; 354(11):1193.
    View in: PubMed
    Score: 0.326
  30. Expression of concern: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. the influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13. N Engl J Med. 2006 Feb 09; 354(6):638.
    View in: PubMed
    Score: 0.324
  31. Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8. N Engl J Med. 2005 12 29; 353(26):2813-4.
    View in: PubMed
    Score: 0.321
  32. Public access to biomedical research. N Engl J Med. 2004 Sep 23; 351(13):1343.
    View in: PubMed
    Score: 0.296
  33. Removal of expression of concern: Schiffl H, et Al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10. N Engl J Med. 2003 Nov 13; 349(20):1965.
    View in: PubMed
    Score: 0.278
  34. Notice of duplicate publication. N Engl J Med. 2003 May 29; 348(22):2254.
    View in: PubMed
    Score: 0.270
  35. Expression of concern: Schiffl H, et Al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-10. N Engl J Med. 2003 05 22; 348(21):2137.
    View in: PubMed
    Score: 0.269
  36. Notice of retraction. N Engl J Med. 2003 Mar 06; 348(10):945.
    View in: PubMed
    Score: 0.264
  37. Retraction: Barbaro et Al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9. N Engl J Med. 2002 Jul 11; 347(2):140.
    View in: PubMed
    Score: 0.254
  38. On authors and contributors. N Engl J Med. 2002 Jul 04; 347(1):55.
    View in: PubMed
    Score: 0.253
  39. Financial associations of authors. N Engl J Med. 2002 Jun 13; 346(24):1901-2.
    View in: PubMed
    Score: 0.252
  40. Too close to call. N Engl J Med. 2001 Sep 13; 345(11):832.
    View in: PubMed
    Score: 0.240
  41. Compounding errors. N Engl J Med. 2012 Dec 20; 367(25):2436-7.
    View in: PubMed
    Score: 0.130
  42. Health of the nation--coverage for all Americans. N Engl J Med. 2008 Aug 21; 359(8):855-6.
    View in: PubMed
    Score: 0.097
  43. Full disclosure and the funding of biomedical research. N Engl J Med. 2008 Apr 24; 358(17):1850-1.
    View in: PubMed
    Score: 0.094
  44. Human papillomavirus vaccine--opportunity and challenge. N Engl J Med. 2007 May 10; 356(19):1990-1.
    View in: PubMed
    Score: 0.089
  45. Tracking the peer-review process. N Engl J Med. 2000 Nov 16; 343(20):1485-6.
    View in: PubMed
    Score: 0.057
  46. H1N1 influenza A disease--information for health professionals. N Engl J Med. 2009 Jun 18; 360(25):2666-7.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.